AP2238

recombinant human AChE Ki 0.0217 microM

General

Type : Multitarget, Coumarin, anti-Abeta-aggregation, Chromen

Chemical_Nomenclature : 3-[4-[[benzyl(methyl)amino]methyl]phenyl]-6,7-dimethoxychromen-2-one

Canonical SMILES : CN(CC1=CC=CC=C1)CC2=CC=C(C=C2)C3=CC4=CC(=C(C=C4OC3=O)OC)OC

InChI : InChI=1S\/C26H25NO4\/c1-27(16-18-7-5-4-6-8-18)17-19-9-11-20(12-10-19)22-13-21-14-24(29-2)25(30-3)15-23(21)31-26(22)28\/h4-15H,16-17H2,1-3H3

InChIKey : KXMCSAUVAHKCOR-UHFFFAOYSA-N

Other name(s) : AP-2238  ||  2H-1-Benzopyran-2-one, 6,7-dimethoxy-3-(4-((methyl(phenylmethyl)amino)methyl)phenyl)-  ||  UNII-545225E0BC  ||  545225E0BC  ||  CHEMBL75121  ||  3-[4-[[benzyl(methyl)amino]methyl]phenyl]-6,7-dimethoxychromen-2-one


MW : 415.5

Formula : C26H25NO4

CAS_number : 553681-56-4

PubChem : 9844749

UniChem : KXMCSAUVAHKCOR-UHFFFAOYSA-N

Target

References (6)

Title : Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation - Zhong_2022_Bioorg.Chem_130_106224
Author(s) : Zhong G , Guo J , Pang C , Su D , Tang C , Jing L , Zhang F , He P , Yan Y , Chen Z , Liu J , Jiang N
Ref : Bioorg Chem , 130 :106224 , 2022
Abstract :
PubMedSearch : Zhong_2022_Bioorg.Chem_130_106224
PubMedID: 36332315

Title : Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives - Montanari_2016_ChemMedChem_11_1296
Author(s) : Montanari S , Bartolini M , Neviani P , Belluti F , Gobbi S , Pruccoli L , Tarozzi A , Falchi F , Andrisano V , Miszta P , Cavalli A , Filipek S , Bisi A , Rampa A
Ref : ChemMedChem , 11 :1296 , 2016
Abstract :
PubMedSearch : Montanari_2016_ChemMedChem_11_1296
PubMedID: 26507467

Title : From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease - Tarozzi_2014_Pharmacol.Res.Perspect_2_e00023
Author(s) : Tarozzi A , Bartolini M , Piazzi L , Valgimigli L , Amorati R , Bolondi C , Djemil A , Mancini F , Andrisano V , Rampa A
Ref : Pharmacol Res Perspect , 2 :e00023 , 2014
Abstract :
PubMedSearch : Tarozzi_2014_Pharmacol.Res.Perspect_2_e00023
PubMedID: 25505579

Title : Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 - Rizzo_2010_Bioorg.Med.Chem_18_1749
Author(s) : Rizzo S , Bartolini M , Ceccarini L , Piazzi L , Gobbi S , Cavalli A , Recanatini M , Andrisano V , Rampa A
Ref : Bioorganic & Medicinal Chemistry , 18 :1749 , 2010
Abstract :
PubMedSearch : Rizzo_2010_Bioorg.Med.Chem_18_1749
PubMedID: 20171894

Title : Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives - Piazzi_2007_J.Med.Chem_50_4250
Author(s) : Piazzi L , Cavalli A , Belluti F , Bisi A , Gobbi S , Rizzo S , Bartolini M , Andrisano V , Recanatini M , Rampa A
Ref : Journal of Medicinal Chemistry , 50 :4250 , 2007
Abstract :
PubMedSearch : Piazzi_2007_J.Med.Chem_50_4250
PubMedID: 17655212

Title : 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy - Piazzi_2003_J.Med.Chem_46_2279
Author(s) : Piazzi L , Rampa A , Bisi A , Gobbi S , Belluti F , Cavalli A , Bartolini M , Andrisano V , Valenti P , Recanatini M
Ref : Journal of Medicinal Chemistry , 46 :2279 , 2003
Abstract :
PubMedSearch : Piazzi_2003_J.Med.Chem_46_2279
PubMedID: 12773032